Mylan Receives Tentative FDA Approval For Pediatric Formulations Of Abacavir/Lamivudine Through Innovative Collaboration With ViiV Healthcare And Clinton Health Access Initiative
December 04, 2014 at 10:01 AM EST
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. ...
